Jump to Main Content
Lung Cancer: A Wily Genetic Opponent
- Hsu, Peggy P., Shaw, Alice T.
- Cell 2017 v.169 pp. 777-779
- DNA, biopsy, lung neoplasms, reports
- In two companion reports, the TRACERx consortium investigates tumor heterogeneity and evolution in early-stage non-small cell lung cancer. The studies highlight the prognostic value of copy-number heterogeneity assessment in tumor biopsies and circulating tumor DNA detection in plasma and suggest that tracking the evolution of lung cancers might aid clinical practice.